I C U Medical Inc (ICUI) 117.68 $ICUI ICU Medical, Inc.

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 3:01 PM

I C U Medical Inc (ICUI) 117.68 $ICUI

ICU Medical, Inc. Announces Time of Second Quarter 2016 Earnings Call
GlobeNewswire - Mon Jul 18, 2:05PM CDT
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its second quarter 2016 earnings release and conference call.
ICUI: 117.68 (+0.92)

Genomic Health to Offer Epic Science's AR-V7 test, Shares Up
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 8:28AM CDT
The availability of the AR-V7 serves as a further development to Genomic Health's (GHDX) recently launched Oncotype SEQ Liquid Select, a next-generation, liquid biopsy test.
ICUI: 117.68 (+0.92), GWPH: 95.94 (+1.62), NUVA: 63.39 (+1.19), GHDX: 30.22 (+1.19)

Walgreen Boots: Q3 a Mixed Bag, Achieves $1B in Synergy
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 8:09AM CDT
In Jun 2016, Walgreens Boots (WBA) was successful in achieving its target of at least $1 billion in combined net synergies from the Alliance Boots deal in fiscal 2016.
ICUI: 117.68 (+0.92), WBA: 79.25 (unch), GWPH: 95.94 (+1.62), NUVA: 63.39 (+1.19)

Illumina Stock Hit by Downbeat Guidance, Stiff Competition
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:27AM CDT
Illumina (ILMN) faces high expenses related to the development of new products, their launch in various markets and investments in partnerships
ICUI: 117.68 (+0.92), NXTM: 22.08 (-0.03), GWPH: 95.94 (+1.62), ILMN: 170.73 (+4.38)

Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:54AM CDT
On Jul 8, 2016, Zacks Investment Research upgraded Halyard Health Inc (HYH) to a Zacks Rank #1 (Strong Buy).
HYH: 34.20 (-0.39), DSCI: 4.73 (-0.04), ICUI: 117.68 (+0.92), NXTM: 22.08 (-0.03)

Henry Schein Rides High on Strategic Buyouts, Price Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Henry Schein's (HSIC) latest acquisition development includes the completion of its takeover of 50% interest in J Morita's subsidiary, One Piece Corp.
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), HSIC: 180.83 (-0.15), NUVA: 63.39 (+1.19)

Walgreens Boots Tops Q3 Earnings, Rite Aid Deal on Track
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 10:46AM CDT
Walgreens Boots (WBA) reported a mixed third-quarter fiscal 2016 with earnings comfortably beating the Zacks Consensus Estimate, while the top line closely missed the mark.
ICUI: 117.68 (+0.92), WBA: 79.25 (unch), GWPH: 95.94 (+1.62), TGTX: 5.77 (-0.14)

Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), ZBH: 130.84 (-0.30), NUVA: 63.39 (+1.19)

FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 6:31AM CDT
With surgical procedures gaining ground in the treatment of drug-resistant epilepsy, the FDA go-ahead will expand Medtronic's (MDT) footprint in the billion-dollar neurosurgical market.
ICUI: 117.68 (+0.92), MDT: 88.18 (+0.55), BAX: 48.54 (+0.52), LMAT: 17.96 (+0.76)

Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 117.68 (+0.92), BAX: 48.54 (+0.52), LMAT: 17.96 (+0.76), HOLX: 38.99 (+0.50)

Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 117.68 (+0.92), LMAT: 17.96 (+0.76), NUVA: 63.39 (+1.19), HRC: 54.04 (+0.61)

Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 117.68 (+0.92), BAX: 48.54 (+0.52), LMAT: 17.96 (+0.76), HOLX: 38.99 (+0.50)

Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 117.68 (+0.92), LMAT: 17.96 (+0.76), BRKR: 24.83 (-0.09), NUVA: 63.39 (+1.19)

Boston Scientific: Restructuring Plan, Global Growth Impress
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 6:14AM CDT
On Jun 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), BAX: 48.54 (+0.52), LMAT: 17.96 (+0.76)

PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 117.68 (+0.92), PETS: 20.73 (unch), LMAT: 17.96 (+0.76), NUVA: 63.39 (+1.19)

Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), ZBH: 130.84 (-0.30), LDRH: 36.98 (-0.02)

NuVasive to Strengthen Spine Service Line with Biotronic Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:17AM CDT
NuVasive, Inc. (NUVA) recently entered into a definitive agreement to acquire privately held Biotronic NeuroNetwork.
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), BAX: 48.54 (+0.52), NUVA: 63.39 (+1.19)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 117.68 (+0.92), ABAX: 49.25 (-0.21), LMAT: 17.96 (+0.76), NUVA: 63.39 (+1.19)

Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 6:31AM CDT
On Jun 3, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), MDT: 88.18 (+0.55), LMAT: 17.96 (+0.76)

Medtronic (MDT) Beats Q4 Earnings & Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:01AM CDT
Medtronic's (MDT) fourth-quarter fiscal 2016 adjusted earnings per share (EPS) came in at $1.27, a penny ahead of the Zacks Consensus Estimate.
BSX: 24.45 (+0.17), ICUI: 117.68 (+0.92), MDT: 88.18 (+0.55), LMAT: 17.96 (+0.76)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...